Sirio Pharma Co., Ltd. (SHE:300791)
China flag China · Delayed Price · Currency is CNY
25.17
-0.04 (-0.16%)
Apr 29, 2025, 3:04 PM CST

Sirio Pharma Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2016 - 2019
Cash & Equivalents
601.24636.03534.491,502715.54216.7
Upgrade
Short-Term Investments
--20109.26--
Upgrade
Trading Asset Securities
90.6115.2200.6679.13530.77473.49
Upgrade
Cash & Short-Term Investments
691.84751.23755.141,6901,246690.2
Upgrade
Cash Growth
14.60%-0.52%-55.32%35.60%80.57%74.56%
Upgrade
Accounts Receivable
680.22702.53652.86476.96372.33307.1
Upgrade
Other Receivables
20.8820.814.994.454.273.13
Upgrade
Receivables
701.1723.34657.85481.41376.6310.22
Upgrade
Inventory
537.94481.66481.06232.58239.61266.77
Upgrade
Other Current Assets
47.0266.7138.8728.5851.9956.64
Upgrade
Total Current Assets
1,9782,0231,9332,4331,9151,324
Upgrade
Property, Plant & Equipment
2,0942,0931,9131,3321,173768.05
Upgrade
Long-Term Investments
215.6552.4494.11-337.79152.22
Upgrade
Goodwill
422.69417.1420.73163.05158.59176.28
Upgrade
Other Intangible Assets
515.19525.92544.84178.33160.75128.97
Upgrade
Long-Term Deferred Tax Assets
93.7981.3632.4813.7516.3133.75
Upgrade
Long-Term Deferred Charges
256.1258.14201.9259.455348.55
Upgrade
Other Long-Term Assets
38.9834.6655.997.146.5717.98
Upgrade
Total Assets
5,6145,4865,1964,1863,8202,650
Upgrade
Accounts Payable
380.16393.43398.13259.25195.71199.52
Upgrade
Accrued Expenses
64.0180.28194.23152.3379.671.21
Upgrade
Short-Term Debt
64.754.82-0.160.121.61
Upgrade
Current Portion of Long-Term Debt
63.6167.6821.25--33.1
Upgrade
Current Portion of Leases
--42.87.265.19-
Upgrade
Current Income Taxes Payable
54.9564.2211.3911.0310.1821.58
Upgrade
Current Unearned Revenue
42.9136.9253.1325.8328.2243.11
Upgrade
Other Current Liabilities
203.97127.1830.213.8413.4316.93
Upgrade
Total Current Liabilities
874.31824.54751.13469.69332.44387.06
Upgrade
Long-Term Debt
1,1641,1561,049908.36852.28-
Upgrade
Long-Term Leases
326.13328.39256.1621.1416.68-
Upgrade
Long-Term Unearned Revenue
57.7559.765.6862.461.4865.25
Upgrade
Long-Term Deferred Tax Liabilities
16.5715.1528.0822.6912.4414.64
Upgrade
Other Long-Term Liabilities
460.78461.44479.470.01--
Upgrade
Total Liabilities
2,9002,8452,6301,4841,275466.94
Upgrade
Common Stock
237.27235.87181.56180.5180.17120
Upgrade
Additional Paid-In Capital
520.75500.7547.51,0481,0451,081
Upgrade
Retained Earnings
1,6911,6231,4961,2781,138978.14
Upgrade
Treasury Stock
-72.9-54.31-44.53---
Upgrade
Comprehensive Income & Other
214.72200.88209.37195.13181.353.75
Upgrade
Total Common Equity
2,5912,5062,3902,7022,5452,183
Upgrade
Minority Interest
123.02135.36176.14-0.010.01
Upgrade
Shareholders' Equity
2,7142,6412,5662,7022,5452,183
Upgrade
Total Liabilities & Equity
5,6145,4865,1964,1863,8202,650
Upgrade
Total Debt
1,6191,6071,369936.9874.2634.71
Upgrade
Net Cash (Debt)
-927.03-855.27-614.1753.08372.05655.49
Upgrade
Net Cash Growth
---102.42%-43.24%121.73%
Upgrade
Net Cash Per Share
-3.97-3.66-2.623.191.502.78
Upgrade
Filing Date Shares Outstanding
234.59236.44234.36234.65234.22234
Upgrade
Total Common Shares Outstanding
234.59236.44234.36234.65234.22234
Upgrade
Working Capital
1,1041,1981,1821,9631,582936.77
Upgrade
Book Value Per Share
11.0510.6010.2011.5110.869.33
Upgrade
Tangible Book Value
1,6531,5631,4242,3602,2251,877
Upgrade
Tangible Book Value Per Share
7.056.616.0810.069.508.02
Upgrade
Buildings
--1,000890.28528.67478.54
Upgrade
Machinery
--1,242974.19773.89645.85
Upgrade
Construction In Progress
--186.9469.28365.12117.96
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.